Richard Knox
Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.
Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.
Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.
He and his wife Jean, an editor, live in Boston. They have two daughters.
-
People under stress are more likely to have health problems, according to a poll by NPR, the Robert Wood Johnson Foundation and the Harvard School of Public Health. That's true for caregivers, too. -
Half of Americans say they've had a major stressful event in the past year, according to a poll by NPR, the Harvard School of Public Health and the Robert Wood Johnson Foundation. Here's how it hurts.
-
Two new drugs for hepatitis C can save lives. They are also wildly expensive, costing $66,000 to $84,000 per person. Insurers face paying billions for treatment, or explicitly rationing vital care.
-
Those people who have contracted the H7N9 virus have become very sick. And unlike the older bird flu virus, this one shows some adaptation to mammals, making it a matter of concern. But it doesn't make chickens sick, posing unique difficulties in fighting this kind of flu.
-
As victims of the Boston Marathon bombings leave the hospital or prepare to, their stories are beginning to pour out. Celeste Corcoran and her daughter, Sydney, both suffered grievous leg injuries. Their accounts give a fuller toll of the attack and the challenges that lie ahead.
-
An international team of disease detectives are in China to investigate an outbreak of a new strain of bird flu, H7N9. The biggest puzzle right now is where these infections are coming from, as testing poultry has turned up very few infected birds.
-
Many injured patients remain in intensive care and in critical condition, which means their condition could still tip toward recovery or death.
-
These days hospitals drill for mass casualty disasters like the explosions at Monday's Boston Marathon. But when it happened for real, the first response was disbelief. Then the victims began arriving. Doctors say they were confronted with the kinds of IED injuries that U.S. troops have gotten in Iraq and Afghanistan.
-
India's Supreme Court says drug maker Novartis can't hold onto its patent for the pricey cancer drug Gleevec simply by tweaking its chemical formula. That means generic drug makers can keep making a form of the drug at a tenth of Novartis's price. Consumer advocates call it a major advance for access to generic drugs. The drug industry says it will chill companies' willingness to produce innovative products.
-
Women who took aspirin at least a couple of times a week for five years or more cut their risk of melanoma by 30 percent. The new study adds to the mounting pile of research suggesting that cheap, common aspirin lowers the risk of many cancers, including colon, breast, esophagus, stomach, prostate, bladder and ovarian cancer.
